secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001104659-23-080583
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharma gets $200K related-party loan, warns it may run out of funds by mid-August
--------------------------------------------------------------------------------

- Received $200,000 loan from AD Pharma (66% owner), total principal now $3,669,279.
- Loan bears interest at 5.25%, matures Dec 31, 2023; default rate 7.5%.
- Proceeds fund operations only through mid-August 2023.
- Without additional financing, company may scale back/terminate operations or seek bankruptcy.
- AD Pharma is controlled by Mr. Schutte, who directly owns ~14% of Acura stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923080583/0001104659-23-080583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923080583/tm2321204d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-080583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer